Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02429843
Title A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

lung cancer

Therapies

Carboplatin + Paclitaxel

Bevacizumab

Carotuximab

Age Groups: adult
Covered Countries USA


No variant requirements are available.